2020 Q3 Form 10-Q Financial Statement
#000156459020048853 Filed on October 29, 2020
Income Statement
| Concept | 2020 Q3 | 2019 Q3 |
|---|---|---|
| Revenue | $235.8M | $255.5M |
| YoY Change | -7.71% | 6.51% |
| Cost Of Revenue | $100.8M | $118.3M |
| YoY Change | -14.78% | 9.69% |
| Gross Profit | $135.0M | $137.2M |
| YoY Change | -1.62% | 3.92% |
| Gross Profit Margin | 57.26% | 53.71% |
| Selling, General & Admin | $80.80M | $86.30M |
| YoY Change | -6.37% | 7.4% |
| % of Gross Profit | 59.84% | 62.88% |
| Research & Development | $49.50M | $59.12M |
| YoY Change | -16.27% | 15.37% |
| % of Gross Profit | 36.66% | 43.07% |
| Depreciation & Amortization | $15.20M | $7.101M |
| YoY Change | 114.05% | 4.69% |
| % of Gross Profit | 11.26% | 5.17% |
| Operating Expenses | $132.1M | $59.12M |
| YoY Change | 123.46% | -56.88% |
| Operating Profit | -$60.00K | $78.13M |
| YoY Change | -100.08% | -1656.94% |
| Interest Expense | $6.663M | $5.164M |
| YoY Change | 29.03% | 46.45% |
| % of Operating Profit | 6.61% | |
| Other Income/Expense, Net | -$887.0K | $558.0K |
| YoY Change | -258.96% | 14.58% |
| Pretax Income | -$7.500M | -$36.14M |
| YoY Change | -79.25% | 371.66% |
| Income Tax | $1.300M | $1.600M |
| % Of Pretax Income | ||
| Net Earnings | -$8.812M | -$37.74M |
| YoY Change | -76.65% | 316.3% |
| Net Earnings / Revenue | -3.74% | -14.77% |
| Basic Earnings Per Share | -$0.07 | |
| Diluted Earnings Per Share | -$0.07 | -$313.6K |
| COMMON SHARES | ||
| Basic Shares Outstanding | 121.7M | 120.8M |
| Diluted Shares Outstanding | 121.7M |
Balance Sheet
| Concept | 2020 Q3 | 2019 Q3 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $193.1M | $161.1M |
| YoY Change | 19.86% | 14.21% |
| Cash & Equivalents | $131.4M | |
| Short-Term Investments | $29.70M | |
| Other Short-Term Assets | $34.10M | $39.00M |
| YoY Change | -12.56% | 10.17% |
| Inventory | $55.83M | $82.39M |
| Prepaid Expenses | ||
| Receivables | $123.6M | $152.3M |
| Other Receivables | $0.00 | $0.00 |
| Total Short-Term Assets | $406.7M | $434.7M |
| YoY Change | -6.44% | 9.83% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $56.00M | $70.61M |
| YoY Change | -20.7% | -7.33% |
| Goodwill | $332.8M | |
| YoY Change | ||
| Intangibles | ||
| YoY Change | ||
| Long-Term Investments | ||
| YoY Change | ||
| Other Assets | $57.30M | $55.00M |
| YoY Change | 4.18% | 8.27% |
| Total Long-Term Assets | $552.8M | $617.1M |
| YoY Change | -10.42% | 83.61% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $406.7M | $434.7M |
| Total Long-Term Assets | $552.8M | $617.1M |
| Total Assets | $959.5M | $1.052B |
| YoY Change | -8.78% | 43.71% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $59.40M | $63.52M |
| YoY Change | -6.48% | 44.69% |
| Accrued Expenses | $132.3M | $149.3M |
| YoY Change | -11.39% | 13.8% |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | $51.52M | $16.52M |
| YoY Change | 211.78% | 83.59% |
| Total Short-Term Liabilities | $435.6M | $411.5M |
| YoY Change | 5.87% | 27.78% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $335.5M | $353.4M |
| YoY Change | -5.08% | 100.23% |
| Other Long-Term Liabilities | $24.19M | $37.92M |
| YoY Change | -36.21% | -65.53% |
| Total Long-Term Liabilities | $359.6M | $391.3M |
| YoY Change | -8.09% | 36.59% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $435.6M | $411.5M |
| Total Long-Term Liabilities | $359.6M | $391.3M |
| Total Liabilities | $949.6M | $802.8M |
| YoY Change | 18.29% | 30.58% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | -$891.2M | |
| YoY Change | ||
| Common Stock | $1.003B | |
| YoY Change | ||
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | $15.00M | |
| YoY Change | ||
| Treasury Stock Shares | $2.366M | |
| Shareholders Equity | $9.911M | $93.85M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $959.5M | $1.052B |
| YoY Change | -8.77% | 43.71% |
Cashflow Statement
| Concept | 2020 Q3 | 2019 Q3 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$8.812M | -$37.74M |
| YoY Change | -76.65% | 316.3% |
| Depreciation, Depletion And Amortization | $15.20M | $7.101M |
| YoY Change | 114.05% | 4.69% |
| Cash From Operating Activities | $24.75M | -$202.0K |
| YoY Change | -12350.0% | -100.59% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | $3.023M | $5.239M |
| YoY Change | -42.3% | -29.36% |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | -$204.0M | |
| YoY Change | -29242.86% | |
| Cash From Investing Activities | -$3.000M | -$209.2M |
| YoY Change | -98.57% | 3026.97% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | $3.581M | $4.136M |
| YoY Change | -13.42% | -42.05% |
| Debt Paid & Issued, Net | $20.10M | |
| YoY Change | 61.23% | |
| Cash From Financing Activities | -22.77M | 171.4M |
| YoY Change | -113.29% | -2195.45% |
| NET CHANGE | ||
| Cash From Operating Activities | 24.75M | -202.0K |
| Cash From Investing Activities | -3.000M | -209.2M |
| Cash From Financing Activities | -22.77M | 171.4M |
| Net Change In Cash | -756.0K | -38.24M |
| YoY Change | -98.02% | -300.96% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | $24.75M | -$202.0K |
| Capital Expenditures | $3.023M | $5.239M |
| Free Cash Flow | $21.72M | -$5.441M |
| YoY Change | -499.23% | -120.22% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2020Q3 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P2Y11M8D | |
| CY2020Q3 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P1Y5M8D | |
| CY2020 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P3Y1M2D | |
| CY2020Q3 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P2Y11M8D | |
| CY2020Q3 | us-gaap |
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
|
P1Y | |
| CY2020Q3 | us-gaap |
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
|
P1Y | |
| CY2020Q3 | us-gaap |
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
|
P1Y | |
| CY2020Q3 | extr |
Standard Hardware Warranty Period
StandardHardwareWarrantyPeriod
|
P1Y | |
| CY2020Q3 | us-gaap |
Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
|
us-gaap:ProductMember | |
| CY2019Q3 | us-gaap |
Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
|
us-gaap:ProductMember | |
| CY2020Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.07 | |
| CY2019Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.31 | |
| CY2020Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
121705000 | |
| CY2019Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
120226000 | |
| CY2020Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8812000 | |
| CY2019Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-37738000 | |
| CY2020Q3 | us-gaap |
Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
|
173000 | |
| CY2020Q3 | extr |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Net Of Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationNetOfTax
|
160000 | |
| CY2020Q3 | us-gaap |
Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease After Adjustments Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsTax
|
-13000 | |
| CY2020Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
1442000 | |
| CY2020Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-7370000 | |
| CY2019Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-37738000 | |
| CY2019Q3 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
4134000 | |
| CY2019Q3 | extr |
Adjustments To Additional Paid In Capital Stock Awards Granted In Connection With Acquisition
AdjustmentsToAdditionalPaidInCapitalStockAwardsGrantedInConnectionWithAcquisition
|
3530000 | |
| CY2019Q3 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
8834000 | |
| CY2019Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
93849000 | |
| CY2020Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
5398000 | |
| CY2020Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8812000 | |
| CY2020Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
1442000 | |
| CY2020Q3 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
8302000 | |
| CY2020Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
9911000 | |
| CY2020Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-8812000 | |
| CY2019Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-37738000 | |
| CY2019Q3 | us-gaap |
Depreciation
Depreciation
|
7101000 | |
| CY2019Q3 | extr |
Reduction In Carrying Amount Of Right Of Use Asset
ReductionInCarryingAmountOfRightOfUseAsset
|
4317000 | |
| CY2020Q3 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
8302000 | |
| CY2020Q3 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
312000 | |
| CY2019Q3 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
357000 | |
| CY2019Q3 | extr |
Non Cash Restructuring And Impairment Charges
NonCashRestructuringAndImpairmentCharges
|
3839000 | |
| CY2020Q3 | us-gaap |
Paid In Kind Interest
PaidInKindInterest
|
1103000 | |
| CY2019Q3 | us-gaap |
Paid In Kind Interest
PaidInKindInterest
|
904000 | |
| CY2020Q3 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-1380000 | |
| CY2019Q3 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
78000 | |
| CY2020Q3 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
910000 | |
| CY2019Q3 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-33490000 | |
| CY2020Q3 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-6628000 | |
| CY2019Q3 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
2108000 | |
| CY2020Q3 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
1521000 | |
| CY2019Q3 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
486000 | |
| CY2020Q3 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
10628000 | |
| CY2019Q3 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-11198000 | |
| CY2020Q3 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-5482000 | |
| CY2019Q3 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-10277000 | |
| CY2020Q3 | extr |
Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
|
-4812000 | |
| CY2019Q3 | extr |
Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
|
-4631000 | |
| CY2020Q3 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
6607000 | |
| CY2019Q3 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
2001000 | |
| CY2020Q3 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
-7934000 | |
| CY2019Q3 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
-3355000 | |
| CY2020Q3 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
24745000 | |
| CY2019Q3 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-202000 | |
| CY2020Q3 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
3023000 | |
| CY2019Q3 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
5239000 | |
| CY2019Q3 | us-gaap |
Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
|
219458000 | |
| CY2019Q3 | us-gaap |
Proceeds From Bank Debt
ProceedsFromBankDebt
|
199500000 | |
| CY2020Q3 | us-gaap |
Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
|
24750000 | |
| CY2019Q3 | us-gaap |
Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
|
20099000 | |
| CY2019Q3 | us-gaap |
Payments Of Loan Costs
PaymentsOfLoanCosts
|
10515000 | |
| CY2020Q3 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
3581000 | |
| CY2019Q3 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
4136000 | |
| CY2020Q3 | us-gaap |
Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
|
603000 | |
| CY2019Q3 | us-gaap |
Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
|
635000 | |
| CY2020Q3 | extr |
Deferred Payments On An Acquisition
DeferredPaymentsOnAnAcquisition
|
1000000 | |
| CY2019Q3 | extr |
Deferred Payments On An Acquisition
DeferredPaymentsOnAnAcquisition
|
1000000 | |
| CY2020Q3 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-22772000 | |
| CY2019Q3 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
171387000 | |
| CY2020Q3 | us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
294000 | |
| CY2019Q3 | us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
-229000 | |
| CY2019Q3 | extr |
Business Acquisition Pro Forma Earnings Per Share Basic And Diluted
BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted
|
-0.20 | |
| CY2019Q3 | extr |
Business Acquisition Pro Forma Shares Used In Earnings Per Share Calculation Basic And Diluted
BusinessAcquisitionProFormaSharesUsedInEarningsPerShareCalculationBasicAndDiluted
|
120226000 | |
| CY2020Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-756000 | |
| CY2019Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-38238000 | |
| CY2020Q2 | us-gaap |
Cash
Cash
|
193872000 | |
| CY2019Q2 | us-gaap |
Cash
Cash
|
169607000 | |
| CY2020Q3 | us-gaap |
Cash
Cash
|
193116000 | |
| CY2019Q3 | us-gaap |
Cash
Cash
|
131369000 | |
| CY2020Q3 | us-gaap |
Fiscal Period
FiscalPeriod
|
<p style="text-align:justify;margin-top:9pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Fiscal Year</p> <p style="text-align:justify;margin-top:9pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company uses a fiscal calendar year ending on June 30. All references herein to “fiscal 2021” or “2021” represent the fiscal year ending June 30, 2021. All references herein to “fiscal 2020” or “2020” represent the fiscal year ended June 30, 2020.</p> | |
| CY2020Q3 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="text-align:justify;margin-top:9pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Accounting Estimates</p> <p style="text-align:justify;margin-top:9pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from these estimates.</p> | |
| CY2020Q3 | extr |
Distribution Channels To Partners
DistributionChannelsToPartners
|
2 | |
| CY2020Q3 | extr |
Contract With Customer Multiple Deliverable Arrangements Determination Of Selling Price Method
ContractWithCustomerMultipleDeliverableArrangementsDeterminationOfSellingPriceMethod
|
Certain of the Company’s contracts have multiple performance obligations, as the promise to transfer individual goods or services is separately identifiable from other promises in the contracts and, therefore, is distinct. For contracts with multiple performance obligations, the Company allocates the contract’s transaction price to each performance obligation based on its relative standalone selling price. The stand-alone selling prices are determined based on the prices at which the Company separately sells these products. For items that are not sold separately, the Company estimates the stand-alone selling prices using the best estimated selling price approach. | |
| CY2020Q3 | us-gaap |
Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
|
297800000 | |
| CY2020Q3 | us-gaap |
Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
|
0.54 | |
| CY2020Q3 | us-gaap |
Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
|
0.25 | |
| CY2020Q3 | us-gaap |
Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
|
0.21 | |
| CY2020Q3 | us-gaap |
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Explanation
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation
|
thereafter | |
| CY2020Q3 | us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
66900000 | |
| CY2019Q3 | us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
53800000 | |
| CY2020Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
235802000 | |
| CY2019Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
255506000 | |
| CY2020Q2 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
111402000 | |
| CY2020Q3 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
48468000 | |
| CY2020Q2 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
52879000 | |
| CY2020Q3 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
7362000 | |
| CY2020Q2 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
9710000 | |
| CY2020Q3 | us-gaap |
Inventory Net
InventoryNet
|
55830000 | |
| CY2020Q2 | us-gaap |
Inventory Net
InventoryNet
|
62589000 | |
| CY2020Q3 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
173574000 | |
| CY2020Q2 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
170215000 | |
| CY2020Q3 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
117579000 | |
| CY2020Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
55995000 | |
| CY2020Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
58813000 | |
| CY2020Q3 | extr |
Standard Software Warranty Period
StandardSoftwareWarrantyPeriod
|
P90D | |
| CY2020Q2 | us-gaap |
Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
|
14035000 | |
| CY2019Q3 | us-gaap |
Standard Product Warranty Accrual Additions From Business Acquisition
StandardProductWarrantyAccrualAdditionsFromBusinessAcquisition
|
570000 | |
| CY2020Q3 | us-gaap |
Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
|
3079000 | |
| CY2019Q3 | us-gaap |
Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
|
5922000 | |
| CY2020Q3 | us-gaap |
Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
|
3630000 | |
| CY2019Q3 | us-gaap |
Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
|
5283000 | |
| CY2020Q3 | us-gaap |
Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
|
13484000 | |
| CY2019Q3 | us-gaap |
Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
|
15988000 | |
| CY2020Q3 | extr |
Deferred Payment Related To Acquisitions
DeferredPaymentRelatedToAcquisitions
|
4891000 | |
| CY2020Q2 | extr |
Deferred Payment Related To Acquisitions
DeferredPaymentRelatedToAcquisitions
|
5847000 | |
| CY2020Q3 | extr |
Other Contractual Obligations Noncurrent
OtherContractualObligationsNoncurrent
|
14715000 | |
| CY2020Q2 | extr |
Other Contractual Obligations Noncurrent
OtherContractualObligationsNoncurrent
|
16722000 | |
| CY2020Q3 | extr |
Other Liabilities Of Other Non Current Liabilities
OtherLiabilitiesOfOtherNonCurrentLiabilities
|
4582000 | |
| CY2020Q2 | extr |
Other Liabilities Of Other Non Current Liabilities
OtherLiabilitiesOfOtherNonCurrentLiabilities
|
5182000 | |
| CY2020Q3 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
24188000 | |
| CY2020Q2 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
27751000 | |
| CY2020Q3 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;"> </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:4.54%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Concentrations</p> <p style="text-align:justify;margin-top:9pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company may be subject to concentration of credit risk as a result of certain financial instruments consisting of accounts receivable and short-term investments. The Company does not invest an amount exceeding 10% of its combined cash and cash equivalents in the securities of any one obligor or maker, except for obligations of the United States government, obligations of United States government agencies and money market accounts. </p> | |
| CY2020Q3 | extr |
Concentration Risk Investment Policy In One Obligor Or Maker Percentage Maximum
ConcentrationRiskInvestmentPolicyInOneObligorOrMakerPercentageMaximum
|
0.10 | |
| CY2020Q3 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
234066000 | |
| CY2020Q3 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
174163000 | |
| CY2020Q3 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
59903000 | |
| CY2020Q2 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
234066000 | |
| CY2020Q2 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
165672000 | |
| CY2020Q2 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
68394000 | |
| CY2020Q3 | us-gaap |
Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
|
6699000 | |
| CY2019Q3 | us-gaap |
Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
|
6495000 | |
| CY2020Q3 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
1792000 | |
| CY2019Q3 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
1930000 | |
| CY2020Q3 | us-gaap |
Adjustment For Amortization
AdjustmentForAmortization
|
8491000 | |
| CY2019Q3 | us-gaap |
Adjustment For Amortization
AdjustmentForAmortization
|
8425000 | |
| CY2020Q3 | us-gaap |
Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
|
2485000 | |
| CY2020Q2 | us-gaap |
Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
|
2484000 | |
| CY2020Q3 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
51515000 | |
| CY2020Q2 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
16516000 | |
| CY2020Q3 | us-gaap |
Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
|
6539000 | |
| CY2020Q2 | us-gaap |
Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
|
7165000 | |
| CY2020Q3 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
335461000 | |
| CY2020Q2 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
394585000 | |
| CY2020Q3 | us-gaap |
Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
|
386976000 | |
| CY2020Q2 | us-gaap |
Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
|
411101000 | |
| CY2020Q3 | us-gaap |
Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
|
7700000 | |
| CY2018Q4 | us-gaap |
Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
|
60000000.0 | |
| CY2018Q4 | extr |
Stock Repurchase Program Authorized Repurchase Amount Per Calendar Year
StockRepurchaseProgramAuthorizedRepurchaseAmountPerCalendarYear
|
30000000.0 | |
| CY2020Q1 | extr |
Stock Repurchase Program Increase In Authorized Amount
StockRepurchaseProgramIncreaseInAuthorizedAmount
|
40000000.0 | |
| CY2020Q1 | us-gaap |
Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
|
100000000.0 | |
| CY2020Q1 | extr |
Stock Repurchase Extended Period
StockRepurchaseExtendedPeriod
|
P3Y | |
| CY2020Q1 | extr |
Stock Repurchase Extended Period Effective Date
StockRepurchaseExtendedPeriodEffectiveDate
|
2020-02-05 | |
| CY2020Q3 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
25893000 | |
| CY2020Q2 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
30878000 | |
| CY2020Q3 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
8302000 | |
| CY2019Q3 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
8834000 | |
| CY2020Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
2922000 | |
| CY2020Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
4.95 | |
| CY2020Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
1688000 | |
| CY2020Q3 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
15000 | |
| CY2020Q3 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
4.18 | |
| CY2020Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
81000 | |
| CY2020Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
5.29 | |
| CY2020Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
2826000 | |
| CY2020Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
4.95 | |
| CY2020Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
1384000 | |
| CY2020Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
2826000 | |
| CY2020Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
4.95 | |
| CY2020Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
1384000 | |
| CY2020Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
1745000 | |
| CY2020Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
3.97 | |
| CY2020Q3 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
1384000 | |
| CY2019Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
3.52 | |
| CY2020Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
7474000 | |
| CY2020Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
6.83 | |
| CY2020Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
5306000 | |
| CY2020Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
4.71 | |
| CY2020Q3 | extr |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Released In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReleasedInPeriod
|
1453000 | |
| CY2020Q3 | extr |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Released In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReleasedInPeriodWeightedAverageGrantDateFairValue
|
7.35 | |
| CY2020Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
|
604000 | |
| CY2020Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
|
9.61 | |
| CY2020Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
10723000 | |
| CY2020Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
5.55 | |
| CY2020Q3 | extr |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested In Period Aggregate Fair Market Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedInPeriodAggregateFairMarketValue
|
43108000 | |
| CY2020Q3 | extr |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestOutstandingNumber
|
10409000 | |
| CY2020Q3 | extr |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Expected To Vest Outstanding Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestOutstandingWeightedAverageGrantDateFairValue
|
5.52 | |
| CY2020Q3 | extr |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Expected To Vest Outstanding Aggregate Fair Market Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestOutstandingAggregateFairMarketValue
|
41843000 | |
| CY2020Q3 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
23800000 | |
| CY2020Q3 | us-gaap |
Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
|
500000 | |
| CY2020Q3 | extr |
Unrecognized Tax Benefit If Recognized That Would Impact Adjustments To Deferred Tax Assets And Valuation Allowances
UnrecognizedTaxBenefitIfRecognizedThatWouldImpactAdjustmentsToDeferredTaxAssetsAndValuationAllowances
|
23300000 | |
| CY2019Q3 | us-gaap |
Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
|
0 | |
| CY2020Q3 | extr |
Restructuring Charges Net Of Reversals
RestructuringChargesNetOfReversals
|
1000000.0 | |
| CY2020Q3 | us-gaap |
Severance Costs1
SeveranceCosts1
|
700000 | |
| CY2020Q3 | extr |
Facility Related Charges
FacilityRelatedCharges
|
300000 | |
| CY2020Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1300000 | |
| CY2019Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1600000 | |
| CY2020Q3 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
|
0 | |
| CY2019Q3 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
|
0 | |
| CY2020Q2 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Acquisition
UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition
|
75000000 | |
| CY2020Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8812000 | |
| CY2019Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-37738000 | |
| CY2020Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
121705000 | |
| CY2019Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
120226000 | |
| CY2020Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.07 | |
| CY2019Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.31 | |
| CY2020Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
12491000 | |
| CY2019Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
12953000 |
